Research Library
Methodology, trial data, and compound reference. Indexed to the primary literature. Free to read.
What Is MOTS-c? The Mitochondrial Peptide, Explained
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA. Research documents AMPK activation, metabolic regulation, and exercise-mimetic signaling, predominantly preclinical.
Peptide CompoundsWhat Is KPV? The Anti-Inflammatory Tripeptide, Explained
KPV (lysine-proline-valine) is the C-terminal tripeptide of α-MSH, studied in preclinical models for NF-κB modulation, PepT1-mediated gut uptake, and intestinal inflammation. Research reference only.
Peptide CompoundsWhat Is GHK-Cu? The Copper Peptide Science, Explained
GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a naturally occurring tripeptide studied for collagen remodeling, gene expression modulation, antioxidant activity, and wound healing. Evidence overview and regulatory status.
Peptide CompoundsGHRP-6 vs GHRP-2 vs Ipamorelin: GHS-R1a Selectivity
GHRP-6, GHRP-2, and ipamorelin all bind GHS-R1a but differ in selectivity: cortisol/prolactin effects, appetite, and evidence tier. Cited comparison for researchers.
Peptide CompoundsGHK-Cu vs BPC-157: ECM Remodeling vs Angiogenesis
GHK-Cu modulates ECM and collagen via copper; BPC-157 drives angiogenesis via VEGF and NO. Mechanism comparison, evidence tiers, and regulatory status.
Peptide CompoundsWhat Is PT-141 (Bremelanotide)? Melanocortin Research
PT-141 (bremelanotide) is a melanocortin MC3R/MC4R receptor agonist studied in Phase 3 trials. Mechanism, evidence tier, FDA and WADA status.
Peptide CompoundsThymosin Alpha-1 vs Beta-4: Key Differences
Thymosin Alpha-1 and Beta-4 are unrelated peptides. Alpha-1 is a 28-aa immune modulator; Beta-4 is a 43-aa actin-binding repair protein. Mechanisms compared.
Peptide CompoundsSelank vs Semax: Neuropeptide Mechanism Comparison
Selank is a tuftsin-derived GABAergic peptide; Semax is an ACTH(4-10) analog studied for BDNF upregulation. Mechanism comparison and evidence tiers.
Peptide CompoundsIpamorelin vs CJC-1295: Mechanism Comparison
Ipamorelin targets GHS-R1a; CJC-1295 targets the GHRH receptor. Cited mechanism comparison, evidence tiers, and WADA status for two GH-axis peptides.